Tuesday, May 17, 2022
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
Home | Business | Zydus Cadila Gets Usfda Nod To Market Liothyronine Sodium Tablets

Zydus Cadila gets USFDA nod to market Liothyronine Sodium tablets

By PTI
Published: Published Date - 05:30 PM, Sat - 23 January 21
Representational Image.

New Delhi: Drug firm Zydus Cadila has received final approval from the US health regulator to market Liothyronine Sodium tablets that are used to treat underactive thyroid.

Liothyronine is a man-made form of thyroid hormone which is used to treat an  underactive thyroid (hypothyroidism).

It replaces or provides more thyroid hormone, which is normally made by the thyroid gland.
Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Liothyronine Sodium tablets USP, 5 mcg, 25 mcg, and 50 mcg, Cadila Healthcare said in a regulatory filing.

Zydus Cadila is a part of the Cadila Healthcare group. The drug will be manufactured at the group’s formulation manufacturing facility at the SEZ, Ahmedabad, the company added.

The group now has 312 approvals and has so far filed over 390 Abbreviated New Drug Applications (ANDAs) since the commencement of the filing process in FY 2003-04.

  • Follow Us :
  • Tags
  • Abbreviated New Drug Application (ANDAs)
  • hypothyroidism
  • Liothyronine
  • thyroid hormone

Related News

  • Pharma industry optimistic about 2022-23 horizon

  • Indian pharma majors to pump in big investments into research

  • India should aim for patent box regime: Industry

  • Covid antiviral drug Molnupiravir launched in India

  • Registration for teens’ vaccination to begin on CoWIN App from Jan 1

  • Covid vaccine exclusively for adolescents likely

Latest News

  • Assam floods: Over 2 lakh people affected in 24 districts of state

    11 mins ago
  • Sensex jumps 930 points; Tata Steel, ITC, Reliance Industries surge

    31 mins ago
  • Rohit Khosla of R.K. International is fading international boundaries to connect people to their dreams

    37 mins ago
  • My kids’ praise for ‘SVP’ was overwhelming: Mahesh Babu

    57 mins ago
  • Makers of Akhil’s ‘Agent’ clarify release on schedule

    1 hour ago
  • Kannada actress dies during fat removal surgery, parents allege negligence

    1 hour ago
  • KTR leaves for UK, Davos visit

    1 hour ago
  • Telangana to launch mass screening drive to identify hypertension and diabetes

    1 hour ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam